Sign in

Amdocs Limited DOX

Price 63.3 USD
as of 2026-09-04
58/100
Mixed
Quality60
Growth47
Balance-sheet strength68
Valuation74
Momentum28
Income79

Composite 58/100; the shares have moved about 30% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 28/100 — a moderate mark against it.

Case for

Income ranks 79/100 — a strong point in its favour. Valuation ranks 74/100 — a moderate point in its favour. Balance-sheet strength ranks 68/100 — a moderate point in its favour.

Case against

Momentum ranks 28/100 — a moderate mark against it. Growth ranks 47/100 — a slight mark against it.

What the company does Amdocs provides cloud-based software and services to communications, media, and entertainment providers, including GenAI-led customer experience suites (CES25) and monetization/orchestration tools.

Key financials Amdocs reports ROE 16%, ROA 8%, and ROCE 15%, with gross/operating/net margins of 38%/17%/12%. Revenue grew 4% YoY while EPS fell 12%. Debt/equity is 0.31 and interest coverage is 18x.

Stock health Momentum is weak: -13% over 3m, -31% over 6m, and -34% over 12m, with RSI at 57. Sideravia scores Valuation 86% (attractive) but Momentum 15% (weak).

Price vs fair value The stock trades at a **discount of 116.80%** to our fair-value estimate of 119.82 and a **discount of 46.91%** to the 12-month target of 81.21. - Earnings growth expected but questioned by Zacks (2026-07-29). - Competitor EXLService’s earnings beat may pressure sentiment (2026-07-28). - High valuation metrics (PEG 0.10, EV/EBITDA 6.84) contrast with weak momentum.

Looking forward Forward P/E of 6.3x and FCF yield of 10% suggest valuation support, but growth (36% below 52-week high) and margin stability remain key watchpoints.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.